SATB2 was found to be overexpressed in a variety of cancers, including colorectal cancer, hepatocellular carcinoma, and neuroendocrine tumors, and played an important role in the occurrence, development, and metastasis of cancers [36,37,38,39,40,41,42,43,44]. Here, SATB2 is linked to colorectal cancer.